Research
-
For secure health care data, thwart the attacks of tomorrow – not yesterday
Proactive measures are the best way to stay ahead of computer hackers who threaten the security of digital health care records, says M. Eric Johnson, dean of Vanderbilt’s Owen Graduate School of Management. Read MoreSep 25, 2013
-
Patterson wins competitive young scholar fellowship
Evelyn Patterson, assistant professor of sociology, is a recipient of a 2013-2014 Woodrow Wilson Foundation Career Enhancement Fellowship for Junior Faculty. Read MoreSep 24, 2013
-
Watershed Event — Vanderbilt ties to ‘worst submarine tragedy’ 50 years ago
Alumnus Pat Garner perished aboard nuclear submarine USS Thresher, which was lost with all 129 hands 50 years ago during deep dive tests 200 miles off the coast of Maine. Steve Krahn, professor of the practice of nuclear environmental engineering, is dedicated to keeping the memory of the Thresher alive. Read MoreSep 24, 2013
-
Second annual Golden Goose Awards presented in Washington
The Golden Goose Award recognizes significant contributions to scientific understanding through federally funded basic research—research conducted with the goal of increasing scientific understanding rather than providing a solution to a specific problem. Read MoreSep 20, 2013
-
Group prenatal care led to improved birth outcomes
Women with access to group prenatal care had improved birth outcomes, including longer gestational periods and higher birth weight, in a study conducted by researchers at Vanderbilt’s Peabody Research Institute. Read MoreSep 19, 2013
-
VU testing vaccine against new flu threat
Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read MoreSep 19, 2013
-
VU study brings genome’s ‘dark matter’ into light
Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read MoreSep 19, 2013
-
Lacy’s crystallographic research achievements recognized
D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and Biochemistry, will receive the 2014 Margaret Etter Award from the American Crystallographic Association (ACA) for outstanding achievement and exceptional potential in crystallographic research demonstrated by a scientist at an early stage of their independent career. Read MoreSep 19, 2013
-
Free online course on data management for clinical research now underway
Vanderbilt University's latest offering on the online learning platform Coursera, "Data Management for Clinical Research," went live this week. More than 33,000 number of students have registered for the massive open online course or MOOC. Read MoreSep 18, 2013
-
The surprising link between social responsibility disclosure and profits
A study out of Vanderbilt University found that corporations that make social responsibility disclosures beyond the norm tend to make more money. Read MoreSep 18, 2013
-
Exodus of physicians to America causing ‘brain drain’ in Africa
The past decade has seen a dramatic rise in the number of physicians trained in Sub-Saharan Africa emigrating to the United States, resulting in a “brain drain” on nations in the greatest need for affordable and accessible health care. Read MoreSep 18, 2013
-
Vanderbilt Medicine: The sequestration era
Efforts by the federal government to control the nation’s spiraling budget deficit, including sequestration that took effect on March 1, have created the potential for significant impact to Medicare’s long-standing support for graduate medical education and could limit the ability of the nation’s academic medical centers to care for patients and train the next generation of physicians, says Donald Brady, senior associate dean of Graduate Medical Education for Vanderbilt University School of Medicine. Read MoreSep 18, 2013
-
Fishing for new anti-cancer drugs
Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read MoreSep 18, 2013
-
Making mixed-income housing work for the poor
Mixed-income neighborhoods help improve the safety and wellbeing of low-income residents, but cannot relieve deeply entrenched poverty or provide upward mobility without additional social services and supports, say Peabody and University of Chicago researchers in a new report. Read MoreSep 17, 2013
-
Constant innovation helped early MOOC course succeed
Constant innovation helped make one of the first massive open online courses, or MOOCs, at Vanderbilt more like a “real class” and benefited faculty and students by improving on-campus teaching, according to Douglas Schmidt, professor of computer science and of computer engineering at Vanderbilt. Read MoreSep 17, 2013
-
Mapping brain membrane proteins
New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues. Read MoreSep 16, 2013
-
The Tennessean: We must walk fine line when it comes to testing
We must make sure that standardized tests actually cover what we all agree is important for children to learn, writes Camilla Benbow, Patricia and Rodes Hart Dean of Education and Human Development. Read MoreSep 16, 2013
-
Cancer nanomedicines on target
Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time. Read MoreSep 13, 2013
-
VU study identifies DNA changes in drug-resistant cancer cells
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read MoreSep 12, 2013
-
VU tracking drug’s ability to prevent type 1 diabetes
Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read MoreSep 12, 2013